Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

227 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A multi-omics based anti-inflammatory immune signature characterizes long COVID-19 syndrome.
Kovarik JJ, Bileck A, Hagn G, Meier-Menches SM, Frey T, Kaempf A, Hollenstein M, Shoumariyeh T, Skos L, Reiter B, Gerner MC, Spannbauer A, Hasimbegovic E, Schmidl D, Garhöfer G, Gyöngyösi M, Schmetterer KG, Gerner C. Kovarik JJ, et al. Among authors: gyongyosi m. iScience. 2023 Jan 20;26(1):105717. doi: 10.1016/j.isci.2022.105717. Epub 2022 Dec 5. iScience. 2023. PMID: 36507225 Free PMC article.
Molecular Imaging of Angiogenesis in Cardiac Regeneration.
Mandic L, Traxler D, Gugerell A, Zlabinger K, Lukovic D, Pavo N, Goliasch G, Spannbauer A, Winkler J, Gyöngyösi M. Mandic L, et al. Among authors: gyongyosi m. Curr Cardiovasc Imaging Rep. 2016;9(10):27. doi: 10.1007/s12410-016-9389-6. Epub 2016 Sep 10. Curr Cardiovasc Imaging Rep. 2016. PMID: 27683600 Free PMC article. Review.
Inhibition of CD34+ cell migration by matrix metalloproteinase-2 during acute myocardial ischemia, counteracted by ischemic preconditioning.
Lukovic D, Zlabinger K, Gugerell A, Spannbauer A, Pavo N, Mandic L, Weidenauer DT, Kastl S, Kaun C, Posa A, Sabdyusheva Litschauer I, Winkler J, Gyöngyösi M. Lukovic D, et al. Among authors: gyongyosi m. F1000Res. 2016 Nov 22;5:2739. doi: 10.12688/f1000research.9957.3. eCollection 2016. F1000Res. 2016. PMID: 28299177 Free PMC article.
Large Animal Models of Heart Failure With Reduced Ejection Fraction (HFrEF).
Spannbauer A, Traxler D, Zlabinger K, Gugerell A, Winkler J, Mester-Tonczar J, Lukovic D, Müller C, Riesenhuber M, Pavo N, Gyöngyösi M. Spannbauer A, et al. Among authors: gyongyosi m. Front Cardiovasc Med. 2019 Aug 14;6:117. doi: 10.3389/fcvm.2019.00117. eCollection 2019. Front Cardiovasc Med. 2019. PMID: 31475161 Free PMC article. Review.
Preclinical development of a miR-132 inhibitor for heart failure treatment.
Foinquinos A, Batkai S, Genschel C, Viereck J, Rump S, Gyöngyösi M, Traxler D, Riesenhuber M, Spannbauer A, Lukovic D, Weber N, Zlabinger K, Hašimbegović E, Winkler J, Fiedler J, Dangwal S, Fischer M, de la Roche J, Wojciechowski D, Kraft T, Garamvölgyi R, Neitzel S, Chatterjee S, Yin X, Bär C, Mayr M, Xiao K, Thum T. Foinquinos A, et al. Among authors: gyongyosi m. Nat Commun. 2020 Jan 31;11(1):633. doi: 10.1038/s41467-020-14349-2. Nat Commun. 2020. PMID: 32005803 Free PMC article.
Multimarker Approach to Identify Patients with Coronary Artery Disease at High Risk for Subsequent Cardiac Adverse Events: The Multi-Biomarker Study.
Giurgea GA, Zlabinger K, Gugerell A, Lukovic D, Syeda B, Mandic L, Pavo N, Mester-Tonczar J, Traxler-Weidenauer D, Spannbauer A, Kastner N, Müller C, Anvari A, Bergler-Klein J, Gyöngyösi M. Giurgea GA, et al. Among authors: gyongyosi m. Biomolecules. 2020 Jun 15;10(6):909. doi: 10.3390/biom10060909. Biomolecules. 2020. PMID: 32549327 Free PMC article.
227 results